Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy

Barbara Ruaro; Ilaria Gandin; Riccardo Pozzan; Stefano Tavano; Chiara Bozzi; Michael Hughes; Metka Kodric; Rossella Cifaldi; Selene Lerda; Marco Confalonieri; Elisa Baratella; Paola Confalonieri; Francesco Salton

doi:10.3390/ph16020307

Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy

Barbara Ruaro, Ilaria Gandin, Riccardo Pozzan, Stefano Tavano, Chiara Bozzi, Michael Hughes, Metka Kodric, Rossella Cifaldi, Selene Lerda, Marco Confalonieri, Elisa Baratella, Paola Confalonieri, Francesco Salton

Division of Musculoskeletal & Dermatological Sciences (L5)

Research output: Contribution to journal › Article › peer-review

Original language	Undefined
Journal	Pharmaceuticals
DOIs	https://doi.org/10.3390/ph16020307
Publication status	Published - Feb 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3390/ph16020307

Cite this

Ruaro, B., Gandin, I., Pozzan, R., Tavano, S., Bozzi, C., Hughes, M., Kodric, M., Cifaldi, R., Lerda, S., Confalonieri, M., Baratella, E., Confalonieri, P., & Salton, F. (2023). Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy. Pharmaceuticals. https://doi.org/10.3390/ph16020307

@article{91612c61541c47c6a33ea279a6fe26ff,

title = "Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy",

author = "Barbara Ruaro and Ilaria Gandin and Riccardo Pozzan and Stefano Tavano and Chiara Bozzi and Michael Hughes and Metka Kodric and Rossella Cifaldi and Selene Lerda and Marco Confalonieri and Elisa Baratella and Paola Confalonieri and Francesco Salton",

year = "2023",

month = feb,

doi = "10.3390/ph16020307",

language = "Undefined",

journal = "Pharmaceuticals",

issn = "1424-8247",

publisher = "MDPI",

}

Ruaro, B, Gandin, I, Pozzan, R, Tavano, S, Bozzi, C, Hughes, M, Kodric, M, Cifaldi, R, Lerda, S, Confalonieri, M, Baratella, E, Confalonieri, P & Salton, F 2023, 'Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy', Pharmaceuticals. https://doi.org/10.3390/ph16020307

TY - JOUR

T1 - Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy

AU - Ruaro, Barbara

AU - Gandin, Ilaria

AU - Pozzan, Riccardo

AU - Tavano, Stefano

AU - Bozzi, Chiara

AU - Hughes, Michael

AU - Kodric, Metka

AU - Cifaldi, Rossella

AU - Lerda, Selene

AU - Confalonieri, Marco

AU - Baratella, Elisa

AU - Confalonieri, Paola

AU - Salton, Francesco

PY - 2023/2

Y1 - 2023/2

UR - https://www.mdpi.com/1424-8247/16/2/307

U2 - 10.3390/ph16020307

DO - 10.3390/ph16020307

M3 - Article

SN - 1424-8247

JO - Pharmaceuticals

JF - Pharmaceuticals

ER -

Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy

UN SDGs

Access to Document

Other files and links

Cite this